Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK)
HKD 0.14
(1.41%)
HKD 0.14
(1.41%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 205.42 Million CNY | 1.18% |
| 2022 | 203.02 Million CNY | 28.53% |
| 2021 | 157.95 Million CNY | 30.69% |
| 2020 | 120.86 Million CNY | -3.12% |
| 2019 | 124.74 Million CNY | 10.26% |
| 2018 | 113.13 Million CNY | -22.76% |
| 2017 | 146.46 Million CNY | 7.11% |
| 2016 | 136.74 Million CNY | -12.11% |
| 2015 | 155.58 Million CNY | 10.7% |
| 2014 | 140.54 Million CNY | 16.4% |
| 2013 | 120.74 Million CNY | -10.14% |
| 2012 | 134.36 Million CNY | 42.44% |
| 2011 | 94.33 Million CNY | 5.48% |
| 2010 | 89.43 Million CNY | 76339.32% |
| 2009 | 117 Thousand CNY | -94.13% |
| 2008 | 1.99 Million CNY | -83.26% |
| 2007 | 11.91 Million CNY | 413.01% |
| 2006 | 2.32 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 201.47 Million CNY | 0.0% |
| 2024 Q1 | - CNY | -100.0% |
| 2023 Q2 | 222.77 Million CNY | 0.0% |
| 2023 Q4 | 205.42 Million CNY | 0.0% |
| 2023 Q3 | - CNY | -100.0% |
| 2023 FY | 205.42 Million CNY | 1.18% |
| 2023 Q1 | - CNY | -100.0% |
| 2022 Q2 | 175.18 Million CNY | 0.0% |
| 2022 Q4 | 203.02 Million CNY | 0.0% |
| 2022 FY | 203.02 Million CNY | 28.53% |
| 2022 Q1 | - CNY | -100.0% |
| 2022 Q3 | - CNY | -100.0% |
| 2021 Q2 | 171.85 Million CNY | 0.0% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 FY | 157.95 Million CNY | 30.69% |
| 2021 Q4 | 157.95 Million CNY | 0.0% |
| 2020 Q2 | 113.48 Million CNY | 0.0% |
| 2020 FY | 120.86 Million CNY | -3.12% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q4 | 120.86 Million CNY | 0.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q2 | 153.54 Million CNY | 0.0% |
| 2019 Q4 | 124.74 Million CNY | 0.0% |
| 2019 FY | 124.74 Million CNY | 10.26% |
| 2018 Q2 | 138.95 Million CNY | 0.0% |
| 2018 FY | 113.13 Million CNY | -22.76% |
| 2018 Q4 | 113.13 Million CNY | 0.0% |
| 2018 Q1 | - CNY | -100.0% |
| 2017 Q2 | 174.39 Million CNY | 0.0% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 FY | 146.46 Million CNY | 7.11% |
| 2017 Q4 | 146.46 Million CNY | 0.0% |
| 2016 Q4 | 136.74 Million CNY | 0.0% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 FY | 136.74 Million CNY | -12.11% |
| 2016 Q2 | 164.75 Million CNY | 0.0% |
| 2015 Q2 | 159.7 Million CNY | 0.0% |
| 2015 Q4 | 155.58 Million CNY | 0.0% |
| 2015 Q1 | - CNY | -100.0% |
| 2015 FY | 155.58 Million CNY | 10.7% |
| 2014 FY | 140.54 Million CNY | 16.4% |
| 2014 Q2 | 114.94 Million CNY | 0.0% |
| 2014 Q4 | 140.54 Million CNY | 0.0% |
| 2014 Q1 | - CNY | -100.0% |
| 2013 Q2 | 142.83 Million CNY | 0.0% |
| 2013 FY | 120.74 Million CNY | -10.14% |
| 2013 Q4 | 120.74 Million CNY | 0.0% |
| 2013 Q1 | - CNY | -100.0% |
| 2012 FY | 134.36 Million CNY | 42.44% |
| 2012 Q4 | 134.36 Million CNY | 0.0% |
| 2012 Q2 | 114.86 Million CNY | 0.0% |
| 2011 Q2 | 86.31 Million CNY | 0.0% |
| 2011 Q4 | 94.33 Million CNY | 0.0% |
| 2011 FY | 94.33 Million CNY | 5.48% |
| 2010 Q2 | 18 Thousand CNY | 0.0% |
| 2010 FY | 89.43 Million CNY | 76339.32% |
| 2010 Q4 | 89.43 Million CNY | 0.0% |
| 2009 Q4 | 117 Thousand CNY | 0.0% |
| 2009 FY | 117 Thousand CNY | -94.13% |
| 2008 FY | 1.99 Million CNY | -83.26% |
| 2007 FY | 11.91 Million CNY | 413.01% |
| 2006 FY | 2.32 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 12.19 Million HKD | -1584.218% |
| Grand Pharmaceutical Group Limited | 1.38 Billion HKD | 85.207% |
| Extrawell Pharmaceutical Holdings Limited | 7.26 Million HKD | -2727.584% |
| Wai Yuen Tong Medicine Holdings Limited | 308.09 Million HKD | 33.325% |
| Qianhai Health Holdings Limited | 431.78 Million HKD | 52.425% |
| Lee's Pharmaceutical Holdings Limited | 298.1 Million HKD | 31.09% |
| Essex Bio-Technology Limited | 62.82 Million HKD | -226.994% |
| Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | -109.049% |
| PuraPharm Corporation Limited | 175.59 Million HKD | -16.986% |
| SSY Group Limited | 1.08 Billion HKD | 81.089% |
| JBM (Healthcare) Limited | 91.58 Million HKD | -124.299% |
| Jacobson Pharma Corporation Limited | 317.85 Million HKD | 35.372% |
| China Resources Pharmaceutical Group Limited | 35.09 Billion HKD | 99.415% |